Ignite Creation Date:
2024-05-06 @ 9:28 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02988843
Status:
TERMINATED
Last Update Posted:
2020-12-10
First Post:
2016-12-01
Brief Title:
Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
Sponsor:
Organization:
Masonic Cancer Center University of Minnesota